As competition to understand early adoption of oral GLP-1s intensifies, manufacturers increasingly seek data partners that can deliver timely, clinically rich insights at scale
Retrived from Alsugair, H
Chang J, Russo A, Bound M, Rayner CK, Jones KL, Horowitz M (2012) A 25-year longitudinal evaluation of gastric emptying in diabetes
Grattis kompis!
Zhong Yao Cai 28(11):991994 Gong N, Fan H, Ma AN, Xiao Q, Wang YX (2014) Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors
Dose, duration, indication of treatment Use of GLP-1 RAs was significantly associated with increased risks of gallbladder or biliary disease at higher doses (RR, 1.56